IONTOPHORETIC DRUG DELIVERY DEVICE AND SOFTWARE APPLICATION

• US 20090149800A1
• Filed: 12/09/2008
• Published: 06/11/2009
• Est. Priority Date: 12/10/2007
• Status: Abandoned Application

• Current Assignee: Iontera, Inc.
• Original Assignee: Isis Biopolymer, LLC
• Inventors: Durand, Emma Amelia
• Application Number:
  US12/330,698
• Publication Number:
  US 20090149800A1
• Time in Patent Office: Days
• US Class Current: 604/20
• CPC Class Codes: A61N 1/303 Constructional details electrodes for external use A61N1/0428
• CPC Class Codes: A61N 1/37247 User interfaces, e.g. input or presentation means
• CPC Class Codes: H05K 1/189 characterised by the use of a flexible or folded printed circuit H05K3/326 takes precedence

Abstract

The iontophoretic drug delivery system includes electrodes controlled by a microprocessor controller to drive charged molecules contained in a drug reservoir through the skin into the issues of a patient. The iontophoretic drug delivery system further includes an antenna connected to the programmable microprocessor. The antenna allows for the programming of the microprocessor and for the exchange of patient, drug, and treatment related information between the microprocessor and an external device. The iontophoretic drug delivery system is also provided with buttons to allow a patient to manually activate the drug delivery system. The iontophoretic drug delivery system is housed within a thin polyester film membrane.

Claims

1. An iontophoretic drug delivery system for driving charged drug molecules into a tissue, comprising:

a flexible patch, comprising;

a drug reservoir holding the charged drug molecules;

an electrode for driving the charged drug molecules into the tissue;

a microprocessor controller configured to control the electrode;

a receiver coupled to the microprocessor controller for enabling the microprocessor controller to be programmed by machine readable programming instructions sent through the receiver; and

a battery coupled to the microprocessor controller;

a software module for creating a set of machine readable programming instructions for the microprocessor to control the operation of the electrode to administer the charged drug molecules held in the drug reservoir; and

a programming device for communicating the machine readable programming instructions to the microprocessor through the receiver.

2. The system of claim 1, wherein the machine readable programming instructions include duration information for turning the electrode ON and OFF.

3. The system of claim 2, wherein the machine readable programming instructions include voltage information for a level of voltage placed across the electrode when turned ON.

4. The system of claim 3, wherein the machine readable programming instructions are selected from a database based upon a type of the charged drug molecules and a patient parameter.

5. The system of claim 3, wherein the machine readable programming instructions are created manually by a user using the software module.

6. The system of claim 1, wherein the microprocessor controller is connected to the electrodes with flexible printed wires.

7. The system of claim 6, wherein the flexible printed wires are made of silver or silver chloride.

8. The system of claim 6, wherein said microprocessor controller and electrodes are connected to the flexible printed wires with a conductive cement.

9. The system of claim 1, further comprising a high-tack adhesive placed around an outer edge of the iontophoretic drug delivery system and a low-tack adhesive placed in a center of the iontophoretic drug delivery system.

10. The system of claim 1, further comprising a tissue permeation enhancer configured to enhance permeation of the drug molecule into the tissue.

11. The system of claim 10, wherein the permeation enhancer is in the reservoir.

12. The system of claim 10, wherein the permeation enhancer is an excipient.

13. The system of claim 1, wherein the programming device connects to the receiver with a wireless connection.

14. The system of claim 1, wherein the programming device connects to the receiver with a wired connection.

15. The system of claim 14, wherein the wired connection is a USB connection.

16. The system of claim 1, further comprising a sensor connected to the microprocessor controller, the sensor being configured to monitor an environmental condition and provide a feedback to the microprocessor controller.

17. The system of claim 16, wherein the environmental condition is selected from the group of environmental conditions consisting of:

moisture, temperature, physical contact between a patient and the iontophoretic drug delivery device, skin temperature, and heart rate.

18. The system of claim 17, wherein in response to the feedback provided by the sensor, the microprocessor control is configured to perform an action selected from the group of actions consisting of:

turning the iontophoretic drug delivery device ON, turning the iontophoretic drug delivery device OFF, and varying a voltage of the electrode.

19. A method of programming an iontophoretic drug delivery device, comprising:

obtaining a set of machine readable iontophoretic programming instructions based on prescription information and user-specific information; and

transmitting the machine readable iontophoretic programming instructions from the system to the iontophoretic drug delivery device.

20. The method of claim 19, wherein the machine readable iontophoretic programming instructions comprise dosage cycle information.

21. The method of claim 19, wherein the machine readable iontophoretic programming instructions comprise prescription concentration level information.

22. The method of claim 19, wherein the iontophoretic drug delivery device comprises an electrode, wherein the machine readable iontophoretic programming instructions comprise time information for regulating time periods during which the electrode is ON and OFF.

23. The method of claim 19, wherein the iontophoretic drug delivery device comprises an electrode, wherein the machine readable iontophoretic programming instructions comprise voltage information for regulating a voltage of the electrode.

24. The method of claim 19, further comprising determining whether a drug interaction can occur from the prescription information.

25. The method of claim 19, further comprising manually creating a set of machine readable iontophoretic programming instructions with a Graphical User Interface.

26. The method of claim 25, wherein manually creating a set of machine readable iontophoretic programming instructions with a Graphical User Interface comprises:

selecting a particular dosage;

selecting a duration for the dosage; and

selecting a dosage period.

27. The method of claim 19, further comprising:

entering patient information into the system; and

forming a label containing at least a portion of the patient information and the prescription information.

28. The method of claim 19, wherein the machine readable iontophoretic programming instructions are transmitted from the system to the iontophoretic drug delivery device wirelessly.

29. The method of claim 19, wherein the machine readable iontophoretic programming instructions are transmitted from the system to the iontophoretic drug delivery device through a wired connection.

30. The method of claim 29, wherein the wired connection is a USB connection.

31. An iontophoretic drug delivery system for driving charged drug molecules into a tissue, comprising:

a flexible patch, comprising;

a drug reservoir holding the charged drug molecules;

an electrode for driving the charged drug molecules into the tissue;

a microprocessor controller configured to control the electrode;

a receiver coupled to the microprocessor controller for enabling the microprocessor controller to be programmed by machine readable programming instructions sent through the receiver; and

a battery coupled to the microprocessor controller; and

a programming device for communicating the machine readable programming instructions to the microprocessor through the receiver.